Delivery Order SPE2DB20D3103-SPE2DB24FP6U7
Award Date
7/26/24
Potential Completion Date
7/29/24
Potential Value
$9.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $9,411.56, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 4565902500 - PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. It is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of September 24, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $12,647.12, is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract has no set-aside designation and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award, valued at $56,671.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a completion date of July 9, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This federal contract award, SPE2DB22D1106|SPE2DB23FEFU6, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,333.23 Firm Fixed Price delivery order is for the provision of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product, with a performance period ending on May 1, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, SPE2DB20D3101|SPE2DB25FRBF2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product, with a ceiling value of $2,583.60 and a completion date of February 7, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside....
This federal contract award is for Delivery Order SPE2DB24FD5Z3 under Indefinite Delivery Contract SPE2DB20D1100, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a ceiling value of $53,831.06 and a performance period ending on September 4, 2024. The contract is a Firm Fixed Price type, with no set-aside designation....
This is a federal contract award made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,326.46, is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 31, 2024. The contract was awarded on December 30, 2024 and does not have a...
This federal contract award, with ID SPE2DB22D1017/SPE2DB24FF4YS, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $7,392.98 firm-fixed-price delivery order is for the supply of the pharmaceutical product Pulmozyme 1 mg/mL ampul 2.5mL. The contract has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support...
The federal contract award, identified as SPE2DX15D1053|SPE2DX25F6CYL, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,127.11 delivery order contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of November 7, 2024. The contract is not...
This federal contract award, with ID SPE2DB22D3501|SPE2DB24FUW24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The $24,109.90 firm fixed price delivery order is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...